Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Yeungnam University College Of Medicine

Clinical trials sponsored by Yeungnam University College Of Medicine, explained in plain language.

Trials to join now! 2
Sort by
  • New eye drug regimen aims to cut injection frequency for PCV patients

    Disease control Recruiting now

    This study tests a personalized treat-and-extend approach using faricimab for people newly diagnosed with polypoidal choroidal vasculopathy (PCV), a form of wet age-related macular degeneration. The goal is to see if this regimen can safely extend the time between eye injections …

    Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control

    Last updated Jun 15, 2026 19:02 UTC

  • New eye drug regimen could mean fewer shots for PCV patients

    Disease control Recruiting now

    This study tests a higher dose (8 mg) of the drug aflibercept, given on a personalized schedule, for people with a specific eye condition called polypoidal choroidal vasculopathy (PCV) that has not been treated before. The goal is to see if this approach can keep the disease unde…

    Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control

    Last updated Jun 15, 2026 19:02 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space